Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

New AMPA and NMDA receptor antagonists in early research at RPR

Oct. 20, 1998

Neurotrophic/neuroprotective agents in development at Sanofi

Oct. 20, 1998

Good efficacy, tolerability reported for Almirall Prodesfarma's antimigraine candidate

Oct. 20, 1998

Statins provide protection against stroke via effects on eNOS

Oct. 20, 1998

Novel CNS technology with broad potential application available from BTG

Oct. 20, 1998

Clinical results cast further doubt on the role of substance P in migraine

Oct. 19, 1998

Verapamil recommended for first-line treatment of cluster headache

Oct. 19, 1998

Subtype-selective 5-HT1D agonists developed at MS&D for migraine

Oct. 19, 1998

Lundbeck describes novel class for psychiatric and neurological disorders

Oct. 19, 1998

CIMA completes study of Zomig using OraSolv technology

Oct. 19, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...